The 474 references in paper Editorial article , Редакционная статья (2016) “Тромбоэмболия легочной артерии: клинические рекомендации Европейского общества кардиологов (2014) // Pulmonary embolism: clinical guidelines of European Society of Cardiology (2014)*” / spz:neicon:pulmonology:y:2015:i:6:p:649-684

1
Heit J.A. The epidemiology of venous thromboembolism in the community. Arterioscler. Thromb. Vasc. Biol. 2008; 28 (3): 370–372.
(check this in PDF content)
2
Cohen A.T., Agnelli G., Anderson F.A. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 2007; 98 (4): 756–764.
(check this in PDF content)
3
Klok F.A., van Kralingen K.W., van Dijk A.P. et al. Quality of life in long-term survivors of acute pulmonary embolism. Chest. 2010; 138 (6): 1432–1440.
(check this in PDF content)
4
Bonderman D., Wilkens H., Wakounig S. et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2009; 33 (2): 325–331.
(check this in PDF content)
5
Condliffe R., Kiely D.G., Gibbs J.S. et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2009; 33 (2): 332–338.
(check this in PDF content)
6
Fanikos J., Piazza G., Zayaruzny M., Goldhaber S.Z. Longterm complications of medical patients with hospitalacquired venous thromboembolism. Thromb. Haemost. 2009; 102 (4): 688–693.
(check this in PDF content)
7
Stein P.D., Henry J.W. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995; 108 (4): 978–981.
(check this in PDF content)
8
Heit J.A. III, Silverstein M.D., Mohr D.N. et al. Risk factors for deep vein thrombosis and pulmonary embolism: a populationbased case-control study. Arch. Intern. Med.2000; 160 (6): 809–815.
(check this in PDF content)
9
Anderson F.A. Jr, Spencer F.A. Risk factors for venous thromboembolism. Circulation. 2003; 107 (23, Suppl. 1): I9–I16.
(check this in PDF content)
10
Bisst. T., Brandão L.R., Kahr W.H. et al. Clinical features and outcome of pulmonary embolism in children.Br. J. Haematol.2008; 142 (5): 808–818.
(check this in PDF content)
11
Andrew M., David M., Adams M. et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994; 83 (5): 1251–1257.
(check this in PDF content)
12
Stein P.D., Kayali F., Olson R.E. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J. Pediatr.2004; 145 (4): 563–565.
(check this in PDF content)
13
Ommen C.H., Heijboer H., Büller H.R. et al. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J. Pediatr. 2001; 139 (5): 676–681.
(check this in PDF content)
14
Kearon C., Akl E.A. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood. 2014; 123 (12): 1794–1801.
(check this in PDF content)
15
Rogers M.A., Levine D.A., Blumberg N. et al. Triggers of hospitalization for venous thromboembolism. Circulation. 2012; 125 (17): 2092–2099.
(check this in PDF content)
16
Ku G.H., White R.H., Chew H.K. et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 2009; 113 (17): 3911–3917.
(check this in PDF content)
17
Chew H.K., Wun T., Harvey D. et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch. Intern. Med. 2006; 166 (4): 458–464.
(check this in PDF content)
18
Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005; 293 (6): 715–722.
(check this in PDF content)
19
Timp J.F., Braekkan S.K., Versteeg H.H., Cannegieter S.C. Epidemiology of cancerassociated venous thrombosis. Blood. 2013; 122 (10): 1712–1723.
(check this in PDF content)
20
Gussoni G., Frasson S., La Regina M. et al. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb. Res.2013; 131 (1): 24–30.
(check this in PDF content)
21
Blanco-Molina A., Rota L.L., Di Micco P. et al. Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb. Haemost. 2010; 103 (2): 306–311.
(check this in PDF content)
22
Blanco-Molina A., Trujillo-Santos J., Tirado R. et al. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb. Haemost. 2009; 101 (3): 478–482.
(check this in PDF content)
23
Pomp E.R., Lenselink A.M., Rosendaal F.R., Doggen C.J. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. Thromb. Haemost. 2008; 6 (4): 632–637.
(check this in PDF content)
24
Henriksson P., Westerlund E., Wallén H. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. Br. Med. J. 2013; 346: e8632.
(check this in PDF content)
25
Sweetland S., Beral V., Balkwill A. et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. Thromb. Haemost. 2012; 10 (11): 2277–2286.
(check this in PDF content)
26
Clayton T.C., Gaskin M., Meade T.W. Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database.Int. J. Epidemiol. 2011; 40 (3): 819–827.
(check this in PDF content)
27
Smeeth L., Cook C., Thomas S. et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367 (9516): 1075–1079.
(check this in PDF content)
28
Khorana A.A., Kuderer N.M., Culakova E. et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008; 111 (10): 4902–4907.
(check this in PDF content)
29
Dijk F.N., Curtin J., Lord D., Fitzgerald D.A. Pulmonary embolismin children. Paediatr. Respir. Rev. 2012; 13 (2): 112–122.
(check this in PDF content)
30
Piazza G., Goldhaber S.Z. Venous thromboembolism and atherothrombosis: an integrated approach. Circulation. 2010; 121 (19): 2146–2150.
(check this in PDF content)
31
Severinsen M.T., Kristensen S.R., Johnsen S.P. et al. Smoking and venous thromboembolism: a Danish follow-up study. Thromb. Haemost.2009; 7 (8): 1297–1303.
(check this in PDF content)
32
Steffen L.M., Cushman M., Peacock J.M. et al. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. Thromb. Haemost. 2009; 7 (5): 746–751.
(check this in PDF content)
33
Ageno W., Becattini C., Brighton T. et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008; 117 (1): 93–102.
(check this in PDF content)
34
Montecucco F., Mach F. Should we focus on «venous vulnerability» instead of «plaque vulnerability» in symptomatic atherosclerotic patients? Thromb. Haemost.2011; 106 (6): 995–996.
(check this in PDF content)
35
Piazza G., Goldhaber S.Z., Lessard D.M. et al. Venous thromboembolism in patients with symptomatic atherosclerosis.Thromb. Haemost.2011; 106 (6): 1095–1102.
(check this in PDF content)
36
Gresele P., Momi S., Migliacci R. Endothelium, venousthromboembolism and ischaemic cardiovascular events. Thromb. Haemost.2010; 103 (1): 56–61.
(check this in PDF content)
37
Fox E.A., Kahn S.R. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb. Haemost. 2005; 94 (2): 362–365.
(check this in PDF content)
38
Enga K.F., Braekkan S.K., Hansen-Krone I.J. et al. Cigarette smoking and the risk of venous thromboembolism: the Tromso Study. Thromb. Haemost.2012; 10 (10): 2068–2074.
(check this in PDF content)
39
Wattanakit K., Lutsey P.L., Bell E.J. et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb. Haemost. 2012; 108 (3): 508–515.
(check this in PDF content)
40
Sørensen H.T., Horvath-Puho E., Lash T.L. et al. Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation. 2011; 124 (13): 1435–1441.
(check this in PDF content)
41
Prandoni P., Pesavento R., Sorensen H.T. et al. Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey.Eur. J. Intern. Med. 2009; 20 (5): 470–473.
(check this in PDF content)
42
Sørensen H.T., Horvath-Puho E., Pedersen L. et al. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007; 370 (9601): 1773–1779.
(check this in PDF content)
43
Kakkar V.V., Howe C.T., Flanc C., Clarke M.B. Natural history of postoperative deepvein thrombosis. Lancet. 1969; 2 (7614): 230–232.
(check this in PDF content)
44
Dalen J.E. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest. 2002; 122 (4): 1440–1456.
(check this in PDF content)
45
Kearon C. Natural history of venous thromboembolism. Circulation. 2003; 107 (23, Suppl. 1): I22–I30.
(check this in PDF content)
46
Aujesky D., Obrosky D.S., Stone R.A. et al. Aprediction rule to identify low-risk patients with pulmonary embolism.Arch. Intern. Med.2006; 166 (2): 169–175.
(check this in PDF content)
47
Laporte S., Mismetti P., Décousus H. et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008; 117 (13): 1711–1716.
(check this in PDF content)
48
Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353 (9162): 1386–1389.
(check this in PDF content)
49
Miniati M., Monti S., Bottai M. et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 2006; 85 (5): 253–262.
(check this in PDF content)
50
Cosmi B., Nijkeuter M., Valentino M. et al. Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism. Intern. Emerg. Med. 2011; 6 (6): 521–528.
(check this in PDF content)
51
Sanchez O., Helley D., Couchon S. et al. Perfusion defects after pulmonary embolism: risk factors and clinical significance. Thromb. Haemost.2010; 8 (6): 1248–1255.
(check this in PDF content)
52
Becattini C., Agnelli G., Pesavento R. et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006; 130 (1): 172–175.
(check this in PDF content)
53
Pengo V., Lensing A.W., Prins M.H. et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N. Engl. J. Med. 2004; 350 (22): 2257–2264.
(check this in PDF content)
54
Kyrle P.A., Rosendaal F.R., Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010; 376 (9757): 2032–2039.
(check this in PDF content)
55
Zhu T., Martinez I., Emmerich J. Venous thromboembolism: risk factors for recurrence.Arterioscler. Thromb. Vasc. Biol. 2009; 29 (3): 298–310.
(check this in PDF content)
56
Heit J.A. Predicting the risk of venous thromboembolism recurrence. Am. J. Hematol.2012; 87 (Suppl. 1): S63–S67.
(check this in PDF content)
57
Heit J.A., Lahr B.D., Petterson T.M. et al. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood. 2011; 118 (18): 4992–4999.
(check this in PDF content)
58
Iorio A., Kearon C., Filippucci E. et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch. Intern. Med.2010; 170 (19): 1710–1716.
(check this in PDF content)
59
Douketis J., Tosetto A., Marcucci M. et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. Br. Med. J. 2011; 342: d813.
(check this in PDF content)
60
Lijfering W.M., Veeger N.J., Middeldorp S. et al. Alower risk of recurrent venous thrombosis inwomencompared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood. 2009; 114 (10): 2031–2036.
(check this in PDF content)
61
Cosmi B., Legnani C., Tosetto A. et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood. 2010; 115 (3): 481–488.
(check this in PDF content)
62
Rodger M.A., Kahn S.R., Wells PS. et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Can. Med. Ass. J.2008; 179 (5): 417–426.
(check this in PDF content)
63
Eichinger S., Minar E., Bialonczyk C. et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA. 2003; 290 (8): 1071–1074.
(check this in PDF content)
64
Coppens M., Reijnders J.H., Middeldorp S. et al. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis.Thromb. Haemost.2008; 6 (9): 1474–1477.
(check this in PDF content)
65
Kearon C., Julian J.A., Kovacs M.J. et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 2008; 112 (12): 4432–4436.
(check this in PDF content)
66
McIntyre K.M., Sasahara A.A. The hemodynamic response to pulmonaryembolism in patients without prior cardiopulmonary disease. Am. J. Cardiol.1971; 28 (3): 288–294.
(check this in PDF content)
67
Smulders Y.M. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc. Res.2000; 48 (1): 23–33.
(check this in PDF content)
68
Delcroix M., Mélot C, Lejeune P. et al. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension. Anesthesiology. 1990; 72 (1): 77–84.
(check this in PDF content)
69
Huet Y., Brun-Buisson C., Lemaire F. et al. Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism. Am. Rev. Respir. Dis.1987; 135 (1): 114–117.
(check this in PDF content)
70
Lankhaar J.W., Westerhof N., Faes T.J. et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension.Am. J. Physiol. Heart Circ. Physiol. 2006; 291 (4): H1731–H1737.
(check this in PDF content)
71
Molloy W.D., Lee K.Y., Girling L. et al. Treatment of shock in a canine model of pulmonary embolism.Am. Rev. Respir. Dis. 1984; 130 (5): 870–874.
(check this in PDF content)
72
Marcus J.T., Gan C.T., Zwanenburg J.J. et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling.J. Am. Coll. Cardiol.2008; 51 (7): 750–757.
(check this in PDF content)
73
Mauritz G.J., Marcus J.T., Westerhof N. et al. Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart. 2011; 97 (6): 473–478.
(check this in PDF content)
74
Begieneman M.P., van de Goot F.R., van der Bilt I.A. et al. Pulmonary embolism causes endomyocarditis in the human heart. Heart. 2008; 94 (4): 450–456.
(check this in PDF content)
75
Hull R.D., Raskob G.E., Hirsh J. et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N. Engl. J. Med.1986; 315 (18): 1109–1114.
(check this in PDF content)
76
Lankeit M., Jiménez D., Kostrubiec M. et al. Predictive value of the high-sensitivity troponin T assay and the simplified pulmonary embolism severity index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011; 124 (24): 2716–2724.
(check this in PDF content)
77
Lankeit M., Kempf T., Dellas C. et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am. J. Respir. Crit. Care Med. 2008; 177 (9): 1018–1025.
(check this in PDF content)
78
Mehta N.J., Jani K., Khan I.A. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism.Am. Heart J.2003; 145 (5): 821–825.
(check this in PDF content)
79
Burrowes K.S., Clark A.R., Tawhai M.H. Blood. flow redistribution and ventilationperfusion mismatch during embolic pulmonary arterial occlusion. Pulm. Circ. 2011; 1 (3): 365–376.
(check this in PDF content)
80
Konstantinides S., Geibel A., Kasper W. et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism (see comments). Circulation. 1998; 97 (19): 1946–1951.
(check this in PDF content)
81
Miniati M., Prediletto R., Formichi B. et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am. J. Respir. Crit. Care Med.1999; 159 (3): 864–871.
(check this in PDF content)
82
Pollack C.V., Schreiber D., Goldhaber S.Z. et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J. Am. Coll. Cardiol.2011; 57 (6): 700–706.
(check this in PDF content)
83
Wells P.S., Ginsberg J.S., Anderson D.R. et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann. Intern. Med. 1998; 129 (12): 997–1005.
(check this in PDF content)
84
Thames M.D., Alpert J.S., Dalen J.E. Syncope in patients with pulmonary embolism. JAMA. 1977; 238 (23): 2509–2511.
(check this in PDF content)
85
Stein P.D., Henry J.W. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest. 1997; 112 (4): 974–979.
(check this in PDF content)
86
White R.H. The epidemiology of venous thromboembolism. Circulation. 2003; 107 (23, Suppl. 1): I4–I8.
(check this in PDF content)
87
Rodger M.A., Carrier M., Jones G.N. et al. Diagnostic value of arterial blood. Gas measurement in suspected pulmonary embolism. Am. J. Respir. Crit. Care Med.2000; 162 (6): 2105–2108.
(check this in PDF content)
88
Stein P.D., Goldhaber S.Z., Henry J.W., Miller A.C. Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest. 1996; 109 (1): 78–81.
(check this in PDF content)
89
Elliott C.G., Goldhaber S.Z., Visani L., DeRosa M. Chest. radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest. 2000; 118 (1): 33–38.
(check this in PDF content)
90
Geibel A., Zehender M., Kasper W. et al. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism.Eur. Respir. J. 2005; 25 (5): 843–848.
(check this in PDF content)
91
Miniati M., Pistolesi M., Marini C. et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED). Am. J. Respir. Crit. Care Med.1996; 154 (5): 1387–1393.
(check this in PDF content)
92
Musset D., Parent F., Meyer G. et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet. 2002; 360 (9349): 1914–1920.
(check this in PDF content)
93
Le Gal G., Righini M., Roy P.M. et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann. Intern. Med. 2006; 144 (3): 165–171.
(check this in PDF content)
94
PIOPED Investigators. Value of the ventilation / perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolismdiagnosis (PIOPED). JAMA. 1990; 263 (20): 2753–2759.
(check this in PDF content)
95
Wells P.S., Anderson D.R., Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb. Haemost. 2000; 83 (3): 416–420.
(check this in PDF content)
96
Anderson D.R., Kovacs M.J., Dennie C. et al. Use of spiral computed tomography contrast angiography and ultrasonography to exclude the diagnosis of pulmonary embolism in the emergency department.J. Emerg. Med. 2005; 29 (4): 399–404.
(check this in PDF content)
97
Kearon C., Ginsberg J.S., Douketis J. et al. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann. Intern. Med.2006; 144 (11): 812–821.
(check this in PDF content)
98
Söhne M., Kamphuisen P.W., van Mierlo P.J., Büller H.R. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly inand outpatients. Thromb. Haemost. 2005; 94 (1): 206–210.
(check this in PDF content)
99
Belle A., Büller H.R., Huisman M.V. et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006; 295 (2): 172–179.
(check this in PDF content)
100
Wells P.S., Anderson D.R., Rodger M. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann. Intern. Med. 2001; 135 (2): 98–107.
(check this in PDF content)
101
Rodger M.A., Maser E., Stiell I. et al. The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism. Thromb. Res. 2005; 116 (2): 101–107.
(check this in PDF content)
102
Runyon M.S., Webb W.B., Jones A.E., Kline J.A. Comparison of the unstructured clinician estimate of pretest probability for pulmonary embolism to the Canadian score and the Charlotte rule: a prospective observational study. Acad. Emerg. Med.2005; 12 (7): 587–593.
(check this in PDF content)
103
Wolf S.J., McCubbin T.R., Feldhaus K.M. et al. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann. Emerg. Med.2004; 44 (5): 503–510.
(check this in PDF content)
104
Ceriani E., Combescure C., Le Gal G. et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis.Thromb. Haemost. 2010; 8 (5): 957–970.
(check this in PDF content)
105
Douma R.A., MosI C., Erkens P.M. et al. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann. Intern. Med.2011; 154 (11): 709–718.
(check this in PDF content)
106
Lucassen W., Geersing G.J., Erkens P.M. et al. Clinical decision rules for excluding pulmonary embolism: a metaanalysis.Ann. Intern. Med.2011; 155 (7): 448–460.
(check this in PDF content)
107
Gibson N.S., Sohne M., Kruip M.J. et al. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb. Haemost.2008; 99 (1): 229–234.
(check this in PDF content)
108
Klok F.A., Mos I.C., Nijkeuter M. et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch. Intern. Med.2008; 168 (19): 2131–2136.
(check this in PDF content)
109
Douma R.A., Gibson N.S., Gerdes V.E. et al. Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb. Haemost.2009; 101 (1): 197–200.
(check this in PDF content)
110
Di Nisio M., Squizzato A., Rutjes A.W. et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. Thromb. Haemost. 2007; 5 (2): 296–304.
(check this in PDF content)
111
Stein P.D., Hull R.D., Patel K.C. et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.Ann. Intern. Med.2004; 140 (8): 589–602.
(check this in PDF content)
112
Perrier A., Roy P.M., Aujesky D. et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am. J. Med. 2004; 116 (5): 291–299.
(check this in PDF content)
113
Perrier A., Roy P.M., Sanchez O. et al. Multidetector-row computed tomography in suspected pulmonary embolism. N. Engl. J. Med. 2005; 352 (17): 1760–1768.
(check this in PDF content)
114
Perrier A., Desmarais S., Miron M.J. et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999; 353 (9148): 190–195.
(check this in PDF content)
115
Kruip M.J., Slob M.J., Schijen J.H. et al. Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Arch. Intern. Med.2002; 162 (14): 1631–1635.
(check this in PDF content)
116
Righini M., Le Gal G., Aujesky D. et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised noninferiority trial. Lancet. 2008; 371 (9621): 1343–1352.
(check this in PDF content)
117
Carrier M., Righini M., Djurabi R.K. et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb. Haemost.2009; 101 (5): 886–892.
(check this in PDF content)
118
Geersing G.J., Erkens P.M., Lucassen W.A. et al. Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. Br. Med. J.2012; 345: e6564.
(check this in PDF content)
119
Righini M., Goehring C., Bounameaux H., Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am. J. Med.2000; 109 (5): 357–361.
(check this in PDF content)
120
Douma R.A., Le G.G., Sohne M. et al. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. Br. Med. J. 2010; 340: c1475.
(check this in PDF content)
121
Penaloza A., Roy P.M., Kline J. et al. Performance of ageadjusted D-dimer cut-off to rule out pulmonary embolism. Thromb. Haemost. 2012; 10 (7): 1291–1296.
(check this in PDF content)
122
Schouten H.J., Geersing G.J., Koek H.L. et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. Br. Med. J. 2013; 346: f2492.
(check this in PDF content)
123
Righini M., Van Es J., den Exter P.L. et al. Age-adjusted Ddimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014; 311 (11): 1117–1124.
(check this in PDF content)
124
Di Nisio M., Söhne M., Kamphuisen P.W., Büller H.R. D-Dimer test in cancer patients with suspected acute pulmonary embolism. Thromb. Haemost.2005; 3 (6): 1239–1242.
(check this in PDF content)
125
Righini M., Le Gal G., De Lucia S. et al. Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb. Haemost. 2006; 95 (4): 715–719.
(check this in PDF content)
126
Miron M.J., Perrier A., Bounameaux H. et al. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur. Respir. J.1999; 13 (6): 1365–1370.
(check this in PDF content)
127
Chabloz P., Reber G., Boehlen F. et al. TAFI antigen and Ddimer levels during normal pregnancy and at delivery. Br. J. Haematol.2001; 115 (1): 150–152.
(check this in PDF content)
128
Francalanci I., Comeglio P., Liotta A.A. et al. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb. Res. 1995; 78 (5): 399–405.
(check this in PDF content)
129
Leclercq M.G., Lutisan J.G., van Marwijk Kooy M. et al. Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study. Thromb. Haemost.2003; 89 (1): 97–103.
(check this in PDF content)
130
Ten Wolde M., Hagen P.J., Macgillavry M.R. et al. Noninvasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study. Thromb. Haemost.2004; 2 (7): 1110–1117.
(check this in PDF content)
131
Ghaye B., Szapiro D., Mastora I. et al. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology. 2001; 219 (3): 629–636.
(check this in PDF content)
132
Patel S., Kazerooni E.A., Cascade P.N. Pulmonary embolism: optimization of small pulmonary artery visualization at multi-detector row CT. Radiology. 2003; 227 (2): 455–460.
(check this in PDF content)
133
Remy-Jardin M., Remy J., Wattinne L., Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique: comparison with pulmonary angiography. Radiology. 1992; 185 (2): 381–387.
(check this in PDF content)
134
Stein P.D., Fowler S.E., Goodman L.R. et al. Multidetector computed tomography for acute pulmonary embolism. N. Engl. J. Med. 2006; 354 (22): 2317–2327.
(check this in PDF content)
135
Anderson D.R., Kahn S.R., Rodger M.A. et al. Computed tomographic pulmonary angiographyvs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA. 2007; 298 (23): 2743–2753.
(check this in PDF content)
136
Carrier M., Righini M., Wells P.S. et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. Thromb. Haemost. 2010; 8 (8): 1716–1722.
(check this in PDF content)
137
Stein P.D., Goodman L.R., Hull R.D. et al. Diagnosis and management of isolated subsegmental pulmonary embolism: reviewand assessment of the options. Clin. Appl. Thromb Hemost.2012; 18 (1): 20–26.
(check this in PDF content)
138
Goodman L.R., Stein P.D., Matta F. et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. Am. J. Roentgenol.2007; 189 (5): 1071–1076.
(check this in PDF content)
139
Brenner D.J., Hall E.J. Computed tomography: an increasing source of radiation exposure. N. Engl. J. Med. 2007; 357 (22): 2277–2284.
(check this in PDF content)
140
Farrell C., Jones M., Girvin F. et al. Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients.Clin. Radiol. 2010; 65 (1): 1–5.
(check this in PDF content)
141
Jia C.F., Li Y.X., Yang Z.Q. et al. Prospective evaluation of unsuspected pulmonary embolism on coronary computed tomographic angiography. J. Comput. Assist. Tomogr. 2012; 36 (2): 187–190.
(check this in PDF content)
142
Palla A., Rossi G., Falaschi F. et al. Is incidentally detected pulmonary embolism in cancer patients less severe? A casecontrol study. Cancer Invest. 2012; 30 (2): 131–134.
(check this in PDF content)
143
Sahut D’Izarn M., Caumont Prim A., Planquette B. et al. Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: a case-control study. Thromb. Haemost. 2012; 10 (10): 2032–2038.
(check this in PDF content)
144
Kearon C., Akl E.A., Comerota A.J. et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9thed.: American College of Chest. Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2, Suppl.): e419S–e494S.
(check this in PDF content)
145
Alderson P.O. Scintigraphic evaluation of pulmonary embolism. Eur. J. Nucl. Med.1987; 13 (Suppl.): S6–10.
(check this in PDF content)
146
Miller R.F., O'Doherty M.J. Pulmonary nuclear medicine. Eur. J. Nucl. Med.1992; 19 (5): 355–368.
(check this in PDF content)
147
Roach P.J., Schembri G.P., Bailey D.L. V/Q scanning using SPECT and SPECT/CT.J. Nucl. Med.2013; 54 (9): 1588–1596.
(check this in PDF content)
148
Schembri G.P., Miller A.E., Smart R. Radiation dosimetry and safety issues in the investigation of pulmonary embolism. Semin. Nucl. Med. 2010; 40 (6): 442–454.
(check this in PDF content)
149
Reid J.H., Coche E.E., Inoue T. et al. Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. Eur. J. Nucl. Med. Mol. Imaging. 2009; 36 (3): 505–521.
(check this in PDF content)
150
Gottschalk A., Sostman H.D., Coleman R.E. et al. Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J. Nucl. Med. 1993; 34 (7): 1119–1126.
(check this in PDF content)
151
Sostman H.D., Coleman R.E., DeLong D.M. et al. Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology. 1994; 193 (1): 103–107.
(check this in PDF content)
152
Bajc M., Olsson B., Palmer J., Jonson B. Ventilation / Perfusion SPECT for diagnostics of pulmonary embolism in clinical practice. J. Intern. Med.2008; 264 (4): 379–387.
(check this in PDF content)
153
Glaser J.E., Chamarthy M., Haramati L.B. et al. Successful and safe implementation of a trinary interpretation and reporting strategy for V/Q lung scintigraphy. J. Nucl. Med. 2011; 52 (10): 1508–1512.
(check this in PDF content)
154
Sostman H.D., Stein P.D., Gottschalk A. et al. Acute pulmonary embolism: sensitivity and specificity of ventilationperfusion scintigraphy in PIOPED II study. Radiology. 2008; 246 (3): 941–946.
(check this in PDF content)
155
Stein P.D., Terrin M.L., Gottschalk A. et al. Value of ventilation / perfusion scans vs. perfusion scans alone in acute pulmonary embolism. Am. J. Cardiol. 1992; 69 (14): 1239–1241.
(check this in PDF content)
156
Miniati M., Monti S., Bauleo C. et al. A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study. Eur. J. Nucl. Med. Mol. Imaging. 2003; 30 (11): 1450–1456.
(check this in PDF content)
157
Roy P.M., Colombet I., Durieux P. et al. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. Br. Med. J.2005; 331 (7511): 259.
(check this in PDF content)
158
Collart J.P., Roelants V., Vanpee D. et al. Is a lung perfusion scan obtained by using single photon emission computed tomography able to improve the radionuclide diagnosis of pulmonary embolism? Nucl. Med. Commun. 2002; 23 (11): 1107–1113.
(check this in PDF content)
159
Corbus H.F., Seitz J.P., Larson R.K. et al. Diagnostic usefulness of lung SPET in pulmonary thromboembolism: an outcome study. Nucl. Med. Commun. 1997; 18 (10): 897–906.
(check this in PDF content)
160
Reinartz P., Wildberger J.E., Schaefer W. et al. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT.J. Nucl. Med. 2004; 45 (9): 1501–1508.
(check this in PDF content)
161
Gutte H., Mortensen J., Jensen C.V. et al. Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography.J. Nucl. Med.2009; 50 (12): 1987–1992.
(check this in PDF content)
162
Reinartz P., Kaiser H.J., Wildberger J.E. et al. SPECT imaging in the diagnosis of pulmonary embolism: automated detection of match and mismatch defects by means of image-processing techniques. J. Nucl. Med. 2006; 47 (6): 968–973.
(check this in PDF content)
163
Beek E.J., Reekers J.A., Batchelor D.A. et al. Feasibility, safety and clinical utility of angiography in patients with suspected pulmonary embolism. Eur. Radiol. 1996; 6 (4): 415–419.
(check this in PDF content)
164
Diffin D.C., Leyendecker J.R., Johnson S.P. et al. Effect of anatomic distribution of pulmonary emboli on interobserver agreement in the interpretation of pulmonary angiography. Am. J. Roentgenol. 1998; 171 (4): 1085–1089.
(check this in PDF content)
165
Stein P.D., Henry J.W., Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreteragreement to the order of the involved pulmonary arterial branch. Radiology. 1999; 210 (3): 689–691.
(check this in PDF content)
166
Miller G.A., Sutton G.C., Kerr I.H. et al. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br. Heart J. 1971; 33 (4): 616.
(check this in PDF content)
167
Stein P.D., Athanasoulis C., Alavi A. et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992; 85 (2): 462–468.
(check this in PDF content)
168
Wan S., Quinlan D.J., Agnelli G., Eikelboom J.W. Thrombolysiscompared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004; 110 (6): 744–749.
(check this in PDF content)
169
Engelberger R.P., Kucher N. Catheter-based reperfusion treatment of pulmonary embolism. Circulation. 2011; 124 (19): 2139–2144.
(check this in PDF content)
170
Revel M.P., Sanchez O., Couchon S. et al. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the IRM-EP study.Thromb. Haemost. 2012; 10 (5): 743–750.
(check this in PDF content)
171
Stein P.D., Chenevert T.L., Fowler S.E. et al. Gadoliniumenhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann. Intern. Med. 2010; 152 (7): 434–3.
(check this in PDF content)
172
Grifoni S., Olivotto I., Cecchini P. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000; 101 (24): 2817– 2822.
(check this in PDF content)
173
Torbicki A., Kurzyna M., Ciurzynski M. et al. Proximal pulmonary emboli modify right ventricular ejection pattern. Eur. Respir. J. 1999; 13 (3): 616–621.
(check this in PDF content)
174
Bova C., Greco F., Misuraca G. et al. Diagnostic utility of echocardiography in patients with suspected pulmonary embolism. Am. J. Emerg. Med. 2003; 21 (3): 180–183.
(check this in PDF content)
175
Kurzyna M., Torbicki A., Pruszczyk P. et al. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am. J. Cardiol. 2002; 90 (5): 507–511.
(check this in PDF content)
176
Casazza F., Bongarzoni A., Capozi A., Agostoni O. Regional right ventricular dysfunction in acute pulmonary embolism and right ventricular infarction. Eur. J. Echocardiogr.2005; 6 (1): 11–14.
(check this in PDF content)
177
Pruszczyk P., Goliszek S., Lichodziejewska B. et al. Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc. Imaging. 2014; 7 (6): 553–560.
(check this in PDF content)
178
Rudski L.G., Lai W.W., Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr.2010; 23 (7): 685–713.
(check this in PDF content)
179
Platz E., Hassanein A.H., Shah A. et al. Regional right ventricular strain pattern in patients with acute pulmonary embolism. Echocardiography. 2012; 29 (4): 464–470.
(check this in PDF content)
180
Sugiura E., Dohi K., Onishi K. et al. Reversible right ventricular regional non-uniformity quantified by speckletracking strain imaging in patients with acute pulmonary thromboembolism. J. Am. Soc. Echocardiogr. 2009; 22 (12): 1353–1359.
(check this in PDF content)
181
Hsiao S.H., Chang S.M., Lee C.Y. et al. Usefulness of tissue Doppler parameters for identifying pulmonary embolism in patients with signs of pulmonary hypertension. Am. J. Cardiol. 2006; 98 (5): 685–690.
(check this in PDF content)
182
Kucher N., Luder C.M., Dörnhöfer T. et al. Novel management strategy for patients with suspected pulmonary embolism. Eur. Heart J.2003; 24 (4): 366–376.
(check this in PDF content)
183
Mansencal N., Attias D., Caille V. et al. Computed tomography for the detection of free-floating thrombi in the right heart in acute pulmonary embolism. Eur. Radiol. 2011; 21 (2): 240–245.
(check this in PDF content)
184
Torbicki A., GalièN., Covezzoli A. et al. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J. Am. Coll. Cardiol. 2003; 41 (12): 2245–2251.
(check this in PDF content)
185
Casazza F., Bongarzoni A., Centonze F., Morpurgo M. Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism. Am. J. Cardiol. 1997; 79 (10): 1433–1435.
(check this in PDF content)
186
Mollazadeh R., Ostovan M.A., Abdi Ardekani A.R. Right cardiac thrombus in transit among patients with pulmonary thromboemboli. Clin. Cardiol.2009; 32 (6): E27–E31.
(check this in PDF content)
187
Rose P.S., Punjabi N.M., Pearse D.B. Treatment of right heart thromboemboli. Chest. 2002; 121 (3): 806–814.
(check this in PDF content)
188
Krivec B., Voga G., Zuran I. et al. Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest. 1997; 112 (5): 1310–1316.
(check this in PDF content)
189
Pruszczyk P., Torbicki A., Kuch-Wocial A. et al. Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism. Heart. 2001; 85 (6): 628–634.
(check this in PDF content)
190
Pruszczyk P., Torbicki A., Pacho R. et al. Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs. spiral CT. Chest. 1997; 112 (3): 722–728.
(check this in PDF content)
191
Hull R.D., Hirsh J., Carter C.J. et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann. Intern. Med.1983; 98 (6): 891–899.
(check this in PDF content)
192
Kearon C., Ginsberg J.S., Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann. Intern. Med. 1998; 129 (12): 1044–1049.
(check this in PDF content)
193
Perrier A., Bounameaux H. Ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann. Intern. Med.1998; 128 (3): 243–245.
(check this in PDF content)
194
Le Gal G., Righini M., Sanchez O. et al. Apositive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb. Haemost. 2006; 95 (6): 963–966.
(check this in PDF content)
195
Elias A., Colombier D., Victor G. et al. Diagnostic performance of complete lower limb venous ultrasound in patients with clinically suspected acute pulmonary embolism. Thromb. Haemost. 2004; 91 (1): 187–195.
(check this in PDF content)
196
Righini M., Le G.G., Aujesky D. et al. Complete venous ultrasound in outpatients with suspected pulmonary embolism. Thromb. Haemost. 2009; 7 (3): 406–412.
(check this in PDF content)
197
Kline J.A., Webb W.B., Jones A.E., Hernandez-Nino J. Impact of a rapid rule-out protocol for pulmonary embolism on the rate of screening, missed cases, and pulmonary vascular imaging in an urban US emergency department.Ann. Emerg. Med.2004; 44 (5): 490–502.
(check this in PDF content)
198
Roy P.M., Meyer G., Vielle B. et al. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann. Intern. Med.2006; 144 (3): 157–164.
(check this in PDF content)
199
Ferrari E., Benhamou M., Berthier F., Baudouy M. Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic treatment. Chest. 2005; 127 (3): 1051–1053.
(check this in PDF content)
200
Pierre-Justin G., Pierard L.A. Management of mobile right heart thrombi: a prospective series.Int. J. Cardiol. 2005; 99 (3): 381–388.
(check this in PDF content)
201
Vieillard-Baron A., Qanadli S.D., Antakly Y. et al. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures.Intensive Care Med. 1998; 24 (5): 429–433.
(check this in PDF content)
202
Righini M., Aujesky D., Roy P.M. et al. Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism. Arch. Intern. Med. 2004; 164 (22): 2483–2487.
(check this in PDF content)
203
Perrier A., Miron M.J., Desmarais S. et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower-limb venous compression ultrasonography?Arch. Intern. Med.2000; 160 (4): 512–516.
(check this in PDF content)
204
Stein P.D., Sostman H.D., Dalen J.E. et al. Controversies in diagnosis of pulmonary embolism. Clin. Appl. Thromb. Hemost. 2011; 17 (2): 140–149.
(check this in PDF content)
205
Exter P.L., Van Es J., Klok F.A. et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood. 2013; 122 (7): 1144–1149.
(check this in PDF content)
206
Wiener R.S., Schwartz L.M., Woloshin S. Whena test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. Br. Med. J. 2013; 347: f3368.
(check this in PDF content)
207
Tsai J., Grosse S.D., Grant A.M. et al. Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch. Intern. Med. 2012; 172 (12): 960–961.
(check this in PDF content)
208
Wiener R.S., Schwartz L.M., Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.Arch. Intern. Med. 2011; 171 (9): 831–837.
(check this in PDF content)
209
Ayaram D., Bellolio M.F., Murad M.H. et al. Triple rule-out computed tomographic angiography for chest pain: a diagnostic systematic review and meta-analysis. Acad. Emerg. Med.2013; 20 (9): 861–871.
(check this in PDF content)
210
Jiménez D., Aujesky D., Díaz G. et al. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am. J. Respir. Crit. Care Med.2010; 181 (9): 983–991.
(check this in PDF content)
211
Chan C.M., Woods C., Shorr A.F. The validation and reproducibility of the pulmonary embolism severity index. Thromb. Haemost. 2010; 8 (7): 1509–1514.
(check this in PDF content)
212
DonzéJ., Le Gal G., Fine M.J. et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb. Haemost. 2008; 100 (5): 943–948.
(check this in PDF content)
213
Vanni S., Nazerian P., Pepe G. et al. Comparison of two prognostic models for acute pulmonary embolism: clinicalvs right ventricular dysfunction-guided approach. Thromb. Haemost.2011; 9 (10): 1916–1923.
(check this in PDF content)
214
Aujesky D., Obrosky D.S., Stone R.A. et al. Derivation and validation of a prognostic model for pulmonary embolism. Am. J. Respir. Crit. Care Med.2005; 172 (8): 1041–1046.
(check this in PDF content)
215
Jiménez D., Yusen R.D., Otero R. et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest. 2007; 132 (1): 24–30.
(check this in PDF content)
216
Wicki J., Perrier A., Perneger T.V. et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb. Haemost. 2000; 84 (4): 548–552.
(check this in PDF content)
217
Aujesky D., Roy P.M., Verschuren F. et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, noninferiority trial. Lancet. 2011; 378 (9785): 41–48.
(check this in PDF content)
218
Jiménez D., Aujesky D., Moores L. et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch. Intern. Med. 2010; 170 (15): 1383–1389.
(check this in PDF content)
219
Righini M., Roy P.M., Meyer G. et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. Thromb. Haemost. 2011; 9 (10): 2115–2117.
(check this in PDF content)
220
Sam A., Sánchez D., Gómez V. et al. The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism. Eur. Respir. J. 2011; 37 (4): 762–766.
(check this in PDF content)
221
Lankeit M., Gomez V., Wagner C. et al. A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism. Chest. 2012; 141 (4): 916–922.
(check this in PDF content)
222
Spirk D., Aujesky D., Husmann M. et al. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous Thromboembolism Registry (SWIVTER). Thromb. Haemost.2011; 106 (5): 978–984.
(check this in PDF content)
223
Kreit J.W. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest. 2004; 125 (4): 1539–1545.
(check this in PDF content)
224
Kucher N., Rossi E., De Rosa M., Goldhaber S.Z. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch. Intern. Med.2005; 165 (15): 1777–1781.
(check this in PDF content)
225
ten Wolde M., Söhne M., Quak E. et al. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch. Intern. Med. 2004; 164 (15): 1685–1689.
(check this in PDF content)
226
Coutance G., Cauderlier E., Ehtisham J. et al. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis.Crit. Care.2011; 15 (2): R103.
(check this in PDF content)
227
Sanchez O., Trinquart L., Colombet I. et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur. Heart J. 2008; 29 (12): 1569–1577.
(check this in PDF content)
228
Becattini C., Agnelli G., Vedovati M.C. et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur. Heart J. 2011; 32 (13): 1657–1663.
(check this in PDF content)
229
Trujillo-Santos J., den Exter P.L., Gómez V. et al. Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and meta-analysis.Thromb. Haemost. 2013; 11 (10): 1823–1832.
(check this in PDF content)
230
Becattini C., Agnelli G., Germini F., Vedovati M.C. Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis.Eur. Respir. J. 2014; 43 (6): 1678–1690.
(check this in PDF content)
231
Henzler T., Roeger S., Meyer M. et al. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. Eur. Respir. J. 2012; 39 (4): 919–926.
(check this in PDF content)
232
Klok F.A., Mos I.C., Huisman M.V. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis.Am. J. Respir. Crit. Care Med. 2008; 178 (4): 425–430.
(check this in PDF content)
233
Kucher N., Goldhaber S.Z. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation. 2003; 108 (18): 2191–2194.
(check this in PDF content)
234
Lankeit M., Jimenez D., Kostrubiec M. et al. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.Eur. Respir. J. 2014; 43 (6): 1669–1677.
(check this in PDF content)
235
Vuilleumier N., Le Gal G., Verschuren F. et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. Thromb. Haemost. 2009; 7 (3): 391–398.
(check this in PDF content)
236
Kostrubiec M., Pruszczyk P., Bochowicz A. et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur. Heart J.2005; 26 (20): 2166–2172.
(check this in PDF content)
237
Agterof M.J., Schutgens R.E., Snijder R.J. et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. Thromb. Haemost.2010; 8 (6): 1235–1241.
(check this in PDF content)
238
Coma-Canella I., Gamallo C., Martinez Onsurbe P., LopezSendon J. Acute right ventricular infarction secondary to massive pulmonary embolism. Eur. Heart J. 1988; 9 (5): 534–540.
(check this in PDF content)
239
Becattini C., Vedovati M.C., Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007; 116 (4): 427–433.
(check this in PDF content)
240
Jiménez D., Uresandi F., Otero R. et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest. 2009; 136 (4): 974–982.
(check this in PDF content)
241
Lankeit M., Friesen D., Aschoff J. et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism.Eur. Heart J.2010; 31 (15): 1836–1844.
(check this in PDF content)
242
Boscheri A., Wunderlich C., Langer M. et al. Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk.Am. Heart J. 2010; 160 (2): 294–300.
(check this in PDF content)
243
Puls M., Dellas C., Lankeit M. et al. Heart-type fatty acidbinding protein permits early risk stratification of pulmonary embolism.Eur. Heart J. 2007; 28 (2): 224–229.
(check this in PDF content)
244
Dellas C., Puls M., Lankeit M. et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J. Am. Coll. Cardiol. 2010; 55 (19): 2150–2157.
(check this in PDF content)
245
Lankeit M., Friesen D., Schafer K. et al. A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin. Res. Cardiol. 2013; 102 (1): 73–80.
(check this in PDF content)
246
Dellas C., Tschepe M., Seeber V. et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb. Haemost. 2014; 111 (5).
(check this in PDF content)
247
Kostrubiec M., Labyk A., Pedowska-Włoszek J. et al. Assessment of renal dysfunction improves troponin-based short-term prognosis in patients with acute symptomatic pulmonary embolism. Thromb. Haemost. 2010; 8 (4): 651–658.
(check this in PDF content)
248
Kostrubiec M., Labyk A., Pedowska-Włoszek J. et al. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism. Heart. 2012; 98 (16): 1221–1228.
(check this in PDF content)
249
Becattini C., Lignani A., Masotti L. et al. D-dimer for risk stratification in patients with acute pulmonary embolism. Thromb. Thrombolysis. 2012; 33 (1): 48–57.
(check this in PDF content)
250
Lobo J.L., Zorrilla V., Aizpuru F. et al. D-dimer levels and 15-day outcome in acute pulmonaryembolism. Findings from the RIETE Registry. Thromb. Haemost.2009; 7 (11): 1795–1801.
(check this in PDF content)
251
Aujesky D., Roy P.M., Guy M. et al. Prognostic value of D-dimer in patients with pulmonary embolism. Thromb. Haemost.2006; 96 (4): 478–482.
(check this in PDF content)
252
Konstantinides S., Geibel A., Heusel G. et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N. Engl. J. Med. 2002; 347 (15): 1143–1150.
(check this in PDF content)
253
Meyer G., Vicaut E., DanaysT. et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N. Engl. J. Med.2014; 370 (15): 1402–1411.
(check this in PDF content)
254
Jiménez D., Aujesky D., Moores LG. et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax. 2011; 66 (1): 75–81.
(check this in PDF content)
255
Agterof M.J., Schutgens R.E., Moumli N. et al. A prognostic model for short term adverse events in normotensive patients with pulmonary embolism. Am. J. Hematol.2011; 86 (8): 646–649.
(check this in PDF content)
256
Becattini C., Casazza F., Forgione C. et al. Acute pulmonary embolism: external validation of an integrated risk stratification model. Chest. 2013; 144 (5): 1539–1545.
(check this in PDF content)
257
Sanchez O., Trinquart L., Caille V. et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am. J. Respir. Crit. Care Med.2010; 181 (2): 168–173.
(check this in PDF content)
258
Jiménez D., Kopecna D., Tapson V. et al. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am. J. Respir. Crit. Care Med. 2014; 189 (6): 718–726.
(check this in PDF content)
259
Bova C., Sanchez O., Prandoni P. et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism.Eur. Respir. J. 2014.
(check this in PDF content)
260
Binder L., Pieske B., Olschewski M. et al. N-terminal probrain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonaryembolism. Circulation. 2005; 112 (11): 1573–1579.
(check this in PDF content)
261
The PEITHO Steering Committee. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am. Heart J.2012; 163 (1): 33–38.
(check this in PDF content)
262
Sanchez O., Trinquart L., Planquette B. et al. Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism. Eur. Respir. J.2013; 42 (3): 681–688.
(check this in PDF content)
263
Ghignone M., Girling L., Prewitt R.M. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology. 1984; 60 (2): 132–135.
(check this in PDF content)
264
Mercat A., Diehl J.L., Meyer G. et al. Hemodynamic effects of fluid loading in acute massive pulmonary embolism.Crit. Care Med. 1999; 27 (3): 540–544.
(check this in PDF content)
265
Manier G., Castaing Y. Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am. Rev. Respir. Dis.1992; 145 (1): 130–136.
(check this in PDF content)
266
Capellier G., Jacques T., Balvay P. et al. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med. 1997; 23 (10): 1089–1092.
(check this in PDF content)
267
Szold O., Khoury W., Biderman P. et al. Inhaled nitric oxide improves pulmonary functions following massive pulmonary embolism: a report of four patients and review of the literature. Lung. 2006; 184 (1): 1–5.
(check this in PDF content)
268
Kerbaul F., Gariboldi V., Giorgi R. et al. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Crit. Care Med. 2007; 35 (8): 1948–1954.
(check this in PDF content)
269
Kjaergaard B., Rasmussen B.S., de Neergaard S. et al. Extracorporeal cardiopulmonary support may be an efficient rescue of patients after massive pulmonary embolism. An experimental porcine study. Thromb. Res. 2012; 129 (4): e147–e151.
(check this in PDF content)
270
Delnoij T.S., Accord R.E., Weerwind P.W., Donker D.W. Atrial trans-septal thrombus in massive pulmonary embolismsalvaged by prolonged extracorporeal life support after thromboembolectomy. A bridge to right-sided cardiovascular adaptation. Acute Card. Care. 2012; 14 (4): 138–140.
(check this in PDF content)
271
Leick J., Liebetrau C., Szardien S. et al. Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary embolism.Clin. Res. Cardiol.2012; 101 (12): 1017–1020.
(check this in PDF content)
272
Taniguchi S., Fukuda W., Fukuda I. et al. Outcome of pulmonary embolectomy for acute pulmonary thromboembolism: analysis of 32 patients from a multicentre registry in Japan.Interact. Cardiovasc. Thorac. Surg.2012; 14 (1): 64–67.
(check this in PDF content)
273
Cossette B., Pelletier M.E., Carrier N. et al. Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative. Ann. Pharmacother.2010; 44 (6): 994–1002.
(check this in PDF content)
274
Dongen C.J., van den Belt A.G., Prins M.H., Lensing A.W. Fixed dose subcutaneous low molecular weight heparins vs. adjusted dose unfractionated heparin for venous thromboembolism.Cochrane Database Syst. Rev. 2004; (4): CD001100.
(check this in PDF content)
275
Stein P.D., Hull R.D., Matta F. et al. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am. J. Med.2009; 122 (10): 919–930.
(check this in PDF content)
276
Prandoni P., Siragusa S., Girolami B., Fabris F. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Blood.2005; 106 (9): 3049–3054.
(check this in PDF content)
277
Raschke R.A., Gollihare B., Peirce J.C. The effectiveness of implementing the weightbased heparin nomogram as a practice guideline. Arch. Intern. Med.1996; 156 (15): 1645–1649.
(check this in PDF content)
278
Lee A.Y., Levine M.N., Baker R.I. et al. Low-molecularweight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N. Engl. J. Med. 2003; 349 (2): 146–153.
(check this in PDF content)
279
Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood. 2011; 118 (20): 5394–5400.
(check this in PDF content)
280
Samama M.M., Poller L. Contemporary laboratory monitoring of low molecular weight heparins. Clin. Lab. Med. 1995; 15 (1): 119–123.
(check this in PDF content)
281
Büller H.R., Davidson B.L., Decousus H. et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N. Engl. J. Med. 2003; 349 (18): 1695–1702.
(check this in PDF content)
282
Warkentin T.E., Maurer B.T., Aster R.H. Heparin-induced thrombocytopenia associated with fondaparinux. N. Engl. J. Med. 2007; 356 (25): 2653–2655.
(check this in PDF content)
283
Garcia D.A., Baglin T.P., Weitz J.I., Samama M.M. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest. Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2, Suppl.): e24S–e43S.
(check this in PDF content)
284
Caterina R., Husted S., Wallentin L. et al. Vitamin K antagonists in heart disease: Current status and perspectives (Section III). Position Paper of the ESCWorking Group on Thrombosis – Task Force on Anticoagulants in Heart Disease. Thromb. Haemost.2013; 110 (6): 1087–1107.
(check this in PDF content)
285
British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet. 1992; 340 (8824): 873–876.
(check this in PDF content)
286
Carlquist J.F., Anderson J.L. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update. Circulation. 2011; 124 (23): 2554–2559.
(check this in PDF content)
287
Epstein R.S., Moyer T.P., Aubert R.E. et al. Warfarin genotyping reduces hospitalization rates results from the MMWES (Medco-Mayo Warfarin Effectiveness study). J. Am. Coll. Cardiol.2010; 55 (25): 2804–2812.
(check this in PDF content)
288
Jonas D.E., McLeod H.L. Genetic and clinical factors relating to warfarin dosing. Trends. Pharmacol. Sci.2009; 30 (7): 375–386.
(check this in PDF content)
289
Anderson J.L., Horne B.D., Stevens S.M. et al. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation. 2012; 125 (16): 1997–2005.
(check this in PDF content)
290
Verhoef T.I., Ragia G., de Boer A. et al. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N. Engl. J. Med.2013; 369 (24): 2304–2312.
(check this in PDF content)
291
Kimmel S.E., French B., Kasner S.E. et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N. Engl. J. Med.2013; 369 (24): 2283–2293.
(check this in PDF content)
292
Pirmohamed M., Burnside G., Eriksson N. et al. A randomized trial of genotype-guided dosing of warfarin. N. Engl. J. Med. 2013; 369 (24): 2294–2303.
(check this in PDF content)
293
Schulman S., Kearon C., Kakkar A.K. et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N. Engl. J. Med.2009; 361 (24): 2342–2352.
(check this in PDF content)
294
Schulman S., Kakkar A.K., Goldhaber S.Z. et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014; 129 (7): 764–772.
(check this in PDF content)
295
Bauersachs R., Berkowitz S.D., Brenner B. et al. Oral rivaroxaban for symptomatic venous thromboembolism. N. Engl. J. Med.2010; 363 (26): 2499–2510.
(check this in PDF content)
296
Büller H.R., Prins M.H., Lensin A.W. et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N. Engl. J. Med.2012; 366 (14): 1287–1297.
(check this in PDF content)
297
Agnelli G., Büller H.R., Cohen A. et al. Oral apixaban for the treatment of acute venous thromboembolism. N. Engl. J. Med.2013; 369 (9): 799–808.
(check this in PDF content)
298
Büller H.R., Decousus H., Grosso M.A. et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N. Engl. J. Med. 2013; 369 (15): 1406–1415.
(check this in PDF content)
299
Hulle T., Kooiman J., den Exter P.L. et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.Thromb. Haemost. 2014; 12 (3): 320–328.
(check this in PDF content)
300
Heidbuchel H., Verhamme P., Alings M. et al. EhrA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur. Heart J. 2013; 34 (27): 2094–2106.
(check this in PDF content)
301
Dalla-Volta S., Palla A., Santolicandro A. et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J. Am. Coll. Cardiol. 1992; 20 (3): 520–526.
(check this in PDF content)
302
Goldhaber S.Z., Haire W.D., Feldstein M.L. et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993; 341 (8844): 507–511.
(check this in PDF content)
303
Becattini C., Agnelli G., Salvi A. et al. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.Thromb. Res.2010; 125 (3): e82–e86.
(check this in PDF content)
304
Konstantinides S., Tiede N., Geibel A. et al. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am. J. Cardiol. 1998; 82 (8): 966–970.
(check this in PDF content)
305
Goldhaber S.Z., Kessler C.M., Heit J. et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet. 1988; 2 (8606): 293–298.
(check this in PDF content)
306
Meneveau N., Schiele F., Vuillemenot A. et al. Streptokinase vs. alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur. Heart J. 1997; 18 (7): 1141–1148.
(check this in PDF content)
307
Meneveau N., Schiele F., Metz D. et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J. Am. Coll. Cardiol. 1998; 31 (5): 1057–1063.
(check this in PDF content)
308
Meyer G., Sors H., Charbonnier B. et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. J. Am. Coll. Cardiol. 1992; 19 (2): 239–245.
(check this in PDF content)
309
Tebbe U., Graf A., Kamke W. et al. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am. Heart J. 1999; 138 (1, Pt 1): 39–44.
(check this in PDF content)
310
Tebbe U., Bramlage P., Graf A. et al. Desmoteplase in acute massive pulmonary thromboembolism. Thromb. Haemost. 2009; 101 (3): 557–562.
(check this in PDF content)
311
Kline J.A., Nordenholz K.E., Courtney D.M. et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at three months (TOPCOAT): Multicenter double-blind, placebo-controlled randomized trial. Thromb. Haemost.2014; 12 (4): 459–468.
(check this in PDF content)
312
Werf F., Ardissino D., Betriu A. et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart J. 2003; 24 (1): 28–66.
(check this in PDF content)
313
Meneveau N., Séronde M.F., Blonde M.C. et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest. 2006; 129 (4): 1043–1050.
(check this in PDF content)
314
Daniels L.B., Parker J.A., Patel S.R. et al. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am. J. Cardiol. 1997; 80 (2): 184–188.
(check this in PDF content)
315
Stein P.D., Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused.Am. J. Med.2012; 125 (5): 465–470.
(check this in PDF content)
316
Kanter D.S., Mikkola K.M., Patel S.R. et al. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997; 111 (5): 1241–1245.
(check this in PDF content)
317
Levine M.N., Goldhaber S.Z., Gore J.M. et al. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest. 1995; 108 (4, Suppl.): 291S–301S.
(check this in PDF content)
318
Mikkola K.M., Patel S.R., Parker J.A. et al. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am. Heart J.1997; 134 (1): 69–72.
(check this in PDF content)
319
Sharifi M., Bay C., Skrocki L. et al. Moderate pulmonary embolism treated with thrombolysis (from the MOPETT Trial). Am. J. Cardiol.2013; 111 (2): 273–277.
(check this in PDF content)
320
Wang C., Zhai Z., Yang Y. et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest. 2010; 137 (2): 254–262.
(check this in PDF content)
321
Chartier L., Büra J., Delomez M. et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation. 1999; 99 (21): 2779–2783.
(check this in PDF content)
322
Kinney E.L., Wright R.J. Efficacy of treatment of patients with echocardiographically detected right-sided heart thrombi: a meta-analysis. Am. Heart J. 1989; 118 (3): 569–573.
(check this in PDF content)
323
Myers P.O., Bounameaux H., Panos A. et al. Impending paradoxical embolism: systematic review of prognostic factors and treatment. Chest. 2010; 137 (1): 164–170.
(check this in PDF content)
324
Mathew T.C., Ramsaran E.K., Aragam J.R. Impending paradoxic embolismin acute pulmonary embolism: diagnosis by transesophageal echocardiography and treatment by emergent surgery. Am. Heart J. 1995; 129 (4): 826–827.
(check this in PDF content)
325
Kilic A., Shah A.S., Conte J.V., Yuh D.D. Nationwide outcomes of surgical embolectomy for acute pulmonary embolism. Thorac. Cardiovasc. Surg.2013; 145 (2): 373–377.
(check this in PDF content)
326
Malekan R., Saunders P.C., Yu C.J. et al. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for highrisk massive pulmonary embolism. Ann. Thorac. Surg. 2012; 94 (1): 104–108.
(check this in PDF content)
327
Takahashi H., Okada K., Matsumori M. et al. Aggressive surgical treatment of acute pulmonary embolism with circulatory collapse.Ann. Thorac. Surg.2012; 94 (3): 785–791.
(check this in PDF content)
328
Leacche M., Unic D., Goldhaber S.Z. et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. Thorac. Cardiovasc. Surg. 2005; 129 (5): 1018–1023.
(check this in PDF content)
329
Aymard T., Kadner A., Widmer A. et al. Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy: should surgical indications be revisited? Eur. J. Cardiothorac. Surg. 2013; 43 (1): 90–94.
(check this in PDF content)
330
Fukuda I., Taniguchi S., Fukui K. et al. Improved outcome of surgical pulmonary embolectomy by aggressive intervention for critically ill patients.Ann. Thorac. Surg. 2011; 91 (3): 728–732.
(check this in PDF content)
331
Aklog L., Williams C.S., Byrne J.G., Goldhaber S.Z. Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002; 105 (12): 1416–1419.
(check this in PDF content)
332
Greelish J.P., Leacche M., Solenkova N.S. et al. Improved midterm outcomes for type A (central) pulmonary emboli treated surgically. Thorac. Cardiovasc. Surg. 2011; 142 (6): 1423–1429.
(check this in PDF content)
333
Vohra H.A., Whistance R.N., Mattam K. et al. Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism.Ann. Thorac. Surg. 2010; 90 (6): 1747–1752.
(check this in PDF content)
334
Kuo W.T., Gould M.K., Louie J.D. et al. Catheterdirected therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. Vasc. Interv. Radiol. 2009; 20 (11): 1431–1440.
(check this in PDF content)
335
Engelberger R.P., Kucher N. Ultrasound-assisted thrombolysis for acute pulmonary embolism: a systematic review. Eur. Heart J. 2014; 35 (12): 758–764.
(check this in PDF content)
336
Kucher N., Boekstegers P., Müller O.J. et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014; 129 (4): 479–486.
(check this in PDF content)
337
Stein P.D., Matta F., Keyes D.C., Willyerd G.L. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism.Am. J. Med. 2012; 125 (5): 478–484.
(check this in PDF content)
338
Muriel A., Jiménez D., Aujesky D. et al. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J. Am. Coll. Cardiol. 2014; 63 (16): 1675–1683.
(check this in PDF content)
339
Hann C.L., Streiff M.B. The role of vena caval filters in the management of venous thromboembolism. Blood. Rev. 2005; 19 (4): 179–202.
(check this in PDF content)
340
Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N. Engl. J. Med.2011; 364 (9): 861–869.
(check this in PDF content)
341
PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005; 112 (3): 416–422.
(check this in PDF content)
342
Failla P.J., Reed K.D., Summer W.R., Karam G.H. Inferior vena caval filters: key considerations. Am. J. Med. Sci 2005; 330 (2): 82–87.
(check this in PDF content)
343
Zhu X., Tam M.D., Bartholomew J. et al. Retrievability and device-related complications of the G2 filter: a retrospective study of 139 filter retrievals.Vasc. Interv. Radiol. 2011; 22 (6): 806–812.
(check this in PDF content)
344
Karmy-Jones R., Jurkovich G.J., Velmahos G.C. et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. Trauma. 2007; 62 (1): 17–24.
(check this in PDF content)
345
Pacouret G., Alison D., Pottier J.M. et al. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch. Intern. Med. 1997; 157 (3): 305–308.
(check this in PDF content)
346
Squizzato A., Donadini M.P., Galli L. et al. Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis. Thromb. Haemost. 2012; 10 (7): 1276–1290.
(check this in PDF content)
347
Zondag W., Mos I.C., Creemers-Schild D. et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. Thromb. Haemost.2011; 9 (8): 1500–1507.
(check this in PDF content)
348
Lankeit M., Konstantinides S. Is it time for home treatment of pulmonary embolism? Eur. Respir. J. 2012; 40 (3): 742–749.
(check this in PDF content)
349
Otero R., Uresandi F., Jiménez D. et al. Home treatment in pulmonary embolism. Thromb. Res. 2010; 126 (1): e1–e5.
(check this in PDF content)
350
Uresandi F., Otero R., Cayuela A. et al. A clinical prediction rule for identifying short-term risk of adverse events in patients with pulmonary thromboembolism. Arch. Bronco* neumol. 2007; 43 (11): 617–622.
(check this in PDF content)
351
Zondag W., Kooiman J., Klok F.A. et al. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis.Eur. Respir. J.2013; 42 (1): 134–144.
(check this in PDF content)
352
Brandjes D.P., Heijboer H., Büller H.R. et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N. Engl. J. Med. 1992; 327 (21): 1485–1489.
(check this in PDF content)
353
Büller H.R., Davidson B.L., Decousus H. et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann. Intern. Med. 2004; 140 (11): 867–873.
(check this in PDF content)
354
Hull R.D., Raskob G.E., Rosenbloom D. et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N. Engl. J. Med. 1990; 322 (18): 1260–1264.
(check this in PDF content)
355
Decousus H., Leizorovicz A., Parent F. et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group [see comments]. N. Engl. J. Med. 1998; 338 (7): 409–415.
(check this in PDF content)
356
Lee A.Y., Rickles F.R., Julian J.A. et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. Clin. Oncol. 2005; 23 (10): 2123–2129.
(check this in PDF content)
357
Kakkar A.K., Levine M.N., Kadziola Z. et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). Clin. Oncol.2004; 22 (10): 1944–1948.
(check this in PDF content)
358
Agnelli G., Prandoni P., Becattini C. et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.Ann. Intern. Med. 2003; 139 (1): 19–25.
(check this in PDF content)
359
Murin S., Romano P.S., White R.H. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb. Haemost. 2002; 88 (3): 407–414.
(check this in PDF content)
360
Schulman S., Granqvist S., Holmström M. et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.N. Engl. J. Med. 1997; 336 (6): 393–398.
(check this in PDF content)
361
Schulman S. The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group. Wien. Med. Wochenschr. 1999; 149 (2–4): 66–69.
(check this in PDF content)
362
Douketis J.D., Gu C.S., Schulman S. et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann. Intern. Med.2007; 147 (11): 766–774.
(check this in PDF content)
363
Schulman S., Rhedin A.S., Lindmarker P. et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N. Engl. J. Med.1995; 332 (25): 1661–1665.
(check this in PDF content)
364
Joung S., Robinson B. Venous thromboembolism in cancer patients in Christchurch, 1995–1999. N. Z. Med. J. 2002; 115 (1155): 257–260.
(check this in PDF content)
365
Hutten B.A., Prins M.H., Gent M. et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.Clin. Oncol. 2000; 18 (17): 3078–3083.
(check this in PDF content)
366
Grifoni S., Vanni S., Magazzini S. et al. Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events.Arch. Intern. Med.2006; 166 (19): 2151–2156.
(check this in PDF content)
367
Palareti G., Cosmi B., Legnani C. et al. D-dimer testing to determine the duration of anticoagulation therapy. N. Engl. J. Med. 2006; 355 (17): 1780–1789.
(check this in PDF content)
368
Becattini C., Agnelli G., Schenone A. et al. Aspirin for preventing the recurrence of venous thromboembolism. N. Engl. J. Med. 2012; 366 (21): 1959–1967.
(check this in PDF content)
369
Brighton T.A., Eikelboom J.W., Mann K. et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N. Engl. J. Med. 2012; 367 (21): 1979–1987.
(check this in PDF content)
370
Schulman S., Kearon C., Kakkar A.K. et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.N. Engl. J. Med. 2013; 368 (8): 709–718.
(check this in PDF content)
371
Agnelli G., Büller H.R., Cohen A. et al. Apixaban for extended treatment of venous thromboembolism. N. Engl. J. Med.2013; 368 (8): 699–708.
(check this in PDF content)
372
Levine M.N., Hirsh J., Gent M. et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb. Haemost. 1995; 74 (2): 606–611.
(check this in PDF content)
373
Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet. 1992; 340 (8824): 873–876.
(check this in PDF content)
374
Campbell I.A., Bentley D.P., Prescott R.J. et al. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. Br. Med. J.2007; 334 (7595): 674.
(check this in PDF content)
375
Kearon C., Gent M., Hirsh J. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism (published erratum appears in N. Engl. J. Med. 1999; 341 (4): 298).N. Engl. J. Med.1999; 340 (12): 901–907.
(check this in PDF content)
376
Akl E.A., Labedi N., Barba M. et al. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst. Rev.2011; (6): CD006650.
(check this in PDF content)
377
Akl E.A., Vasireddi S.R., Gunukula S. et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst. Rev. 2011; (4): CD006649.
(check this in PDF content)
378
Pepke-Zaba J., Jansa P., Kim N.H. et al. Chronic thromboembolic pulmonary hypertension: role of medical therapy. Eur. Respir. J. 2013; 41 (4): 985–990.
(check this in PDF content)
379
GalièN., Hoeper M.M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension.Eur. Respir. J.2009; 34 (6): 1219–1263.
(check this in PDF content)
380
Simonneau G., Gatzoulis M.A., Adatia I. et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol.2013; 62 (25, Suppl.): D34–D41.
(check this in PDF content)
381
Lang I.M., Pesavento R., Bonderman D., Yuan J.X. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur. Respir. J. 2013; 41 (2): 462–468.
(check this in PDF content)
382
Lang I.M., Simonneau G., Pepke-Zaba J.W. et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb. Haemost.2013; 110 (1): 83-91.
(check this in PDF content)
383
Wong C.L., Szydlo R., Gibbs S., Laffan M. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood. Coagul. Fibrinolysis. 2010; 21 (3): 201–206.
(check this in PDF content)
384
Bonderman D., Jakowitsch J., Redwan B. et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 2008; 28 (4): 678–684.
(check this in PDF content)
385
Quarck R., Nawrot T., Meyns B., Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2009; 53 (14): 1211–1218.
(check this in PDF content)
386
Firth A.L., Yao W., Ogawa A. et al. Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am. J. Physiol. Cell. Physiol.2010; 298 (5): C1217–C1225.
(check this in PDF content)
387
Yao W., Firth A.L., Sacks R.S. et al. Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009; 296 (6): L870–L878.
(check this in PDF content)
388
Morris T.A., Marsh J.J., Chiles P.G. et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 2009; 114 (9): 1929–1936.
(check this in PDF content)
389
Bonderman D., Skoro-Sajer N., Jakowitsch J. et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007; 115 (16): 2153–2158.
(check this in PDF content)
390
Delcroix M., Vonk Noordegraaf A., Fadel E. et al. Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2013; 41 (1): 224–232.
(check this in PDF content)
391
Madani M.M., Auger W.R., Pretorius V. et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann. Thorac. Surg. 2012; 94 (1): 97–103.
(check this in PDF content)
392
Pepke-Zaba J., Delcroix M., Lang I. et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011; 124 (18): 1973–1981.
(check this in PDF content)
393
Berger R.M., Beghetti M., Humpl T. et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet. 2012; 379 (9815): 537–546.
(check this in PDF content)
394
Beghetti M., Berger R.M., Schulze-Neick I. et al. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice. Eur. Respir. J. 2013; 42 (3): 689–700.
(check this in PDF content)
395
Tunariu N., Gibbs S.J., Win Z. et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J. Nucl. Med. 2007; 48 (5): 680–684.
(check this in PDF content)
396
Seferian A., Helal B., Jaїs X. et al. Ventilation / perfusion lung scan in pulmonary veno-occlusive disease. Eur. Respir. J.2012; 40 (1): 75–83.
(check this in PDF content)
397
Lang I.M., Plank C., Sadushi-Kolici R. et al. Imaging in pulmonary hypertension. JACC Cardiovasc. Imaging. 2010; 3 (12): 1287–1295.
(check this in PDF content)
398
Mayer E., Jenkins D., Lindner J. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Thorac. Cardiovasc. Surg. 2011; 141 (3): 702–710.
(check this in PDF content)
399
Cummings K.W., Bhalla S. Multidetector computed tomographic pulmonary angiography: beyond acute pulmonary embolism.Radiol. Clin. North Am.2010; 48 (1): 51–65.
(check this in PDF content)
400
Sherrick A.D., Swensen S.J., Hartman T.E. Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes.Am. J. Roentgenol. 1997; 169 (1): 79–82.
(check this in PDF content)
401
Ley S., Ley-Zaporozhan J., Pitton M.B. et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur. Radiol. 2012; 22 (3): 607–616.
(check this in PDF content)
402
Shure D., Gregoratos G., Moser K.M. Fiberoptic angioscopy: role in the diagnosis of chronic pulmonary arterial obstruction.Ann. Intern. Med. 1985; 103 (6, Pt 1): 844–850.
(check this in PDF content)
403
Jenkins D.P., Madani M., Mayer E. et al. Surgical treatment of chronic thromboembolic pulmonary hypertension.Eur. Respir. J. 2013; 41 (3): 735–742.
(check this in PDF content)
404
Vuylsteke A., Sharples L., Charman G. et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet. 2011; 378 (9800): 1379–1387.
(check this in PDF content)
405
Mizoguchi H., Ogawa A., Munemasa M. et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ. Cardiovasc. Interv. 2012; 5 (6): 748–755.
(check this in PDF content)
406
Andreassen A.K., Ragnarsson A., Gude E. et al. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013; 99 (19): 1415–20.
(check this in PDF content)
407
Inami T., Kataoka M., Shimura N. et al. Pulmonary Edema Predictive Scoring Index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc. Interv. 2013; 6 (7): 725–736.
(check this in PDF content)
408
Kataoka M., Inami T., Hayashida K. et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ. Cardiovasc. Interv.2012; 5 (6): 756–762.
(check this in PDF content)
409
Pepke-Zaba J., Jansa P., Kim N.H. et al. Chronic thromboembolic pulmonary hypertension: Role of medical therapy. Eur. Respir. J. 2013; 41 (4): 985–90.
(check this in PDF content)
410
Jais X., D’Armini A.M., Jansa P. et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFIT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J. Am. Coll. Cardiol. 2008; 52 (25): 2127–2134.
(check this in PDF content)
411
Ghofrani H.A., D'Armini A.M., Grimminger F. et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N. Engl. J. Med. 2013; 369 (4): 319–329.
(check this in PDF content)
412
Kim N.H., Delcroix M., Jenkins D.P. et al. Chronic thromboembolic pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62 (25, Suppl.): D92–D99.
(check this in PDF content)
413
Jamieson S.W., Kapelanski D.P., Sakakibara N. et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann. Thorac. Surg. 2003; 76 (5): 1457–1462.
(check this in PDF content)
414
Rubin L.J., Hoeper M.M., Klepetko W. et al. Current and future management of chronic thromboembolic pulmonary hypertension: from diagnosis to treatment responses. Proc. Am. Thorac. Soc. 2006; 3 (7): 601–607.
(check this in PDF content)
415
Sullivan E.A., Ford J.B., Chambers G., Slaytor E.K. Maternal mortality in Australia, 1973–1996. Aust. N. Z. J. Obstet. Gynaecol.2004; 44 (5): 452–457.
(check this in PDF content)
416
Regitz-Zagrosek V., Blomstrom L.C., Borghi C. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur. Heart J. 2011; 32 (24): 3147–3197.
(check this in PDF content)
417
O'Connor C., Moriarty J., Walsh J. et al. The application of a clinical risk stratification score may reduce unnecessary investigations for pulmonary embolism in pregnancy. Matern. Fetal. Neonatal. Med.2011; 24 (12): 1461–1464.
(check this in PDF content)
418
Chan W.S., Chunilal S., Lee A. et al. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy.Ann. Intern. Med.2007; 147 (3): 165–170.
(check this in PDF content)
419
Chan W.S., Lee A., Spencer F.A. et al. D-dimer testing in pregnant patients: towards determining the next ’level’ in the diagnosis of deep vein thrombosis. Thromb. Haemost. 2010; 8 (5): 1004–1011.
(check this in PDF content)
420
Ginsberg J.S., Hirsh J., Rainbow A.J., Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb. Haemost. 1989; 61 (2): 189–196.
(check this in PDF content)
421
Einstein A.J., Henzlova M.J., Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007; 298 (3): 317–323.
(check this in PDF content)
422
Revel M.P., Cohen S., Sanchez O. et al. Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography? Radiology. 2011; 258 (2): 590–598.
(check this in PDF content)
423
Shahir K., Goodman L.R., Tali A. et al. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning.Am. J. Roentgenol. 2010; 195 (3): W214–W220.
(check this in PDF content)
424
Cahill A.G., Stout M.J., Macones G.A., Bhalla S. Diagnosing pulmonary embolism in pregnancy using computed-tomographic angiography or ventilation-perfusion. Obstet. Gynecol.2009; 114 (1): 124–129.
(check this in PDF content)
425
Ridge C.A., McDermott S., Freyne B.J. et al. Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. Am. J. Roentgenol. 2009; 193 (5): 1223–1227.
(check this in PDF content)
426
Scarsbrook A.F., Bradley K.M., Gleeson F.V. Perfusion scintigraphy: diagnostic utility in pregnant women with suspected pulmonary embolic disease. Eur. Radiol.2007; 17 (10): 2554–2560.
(check this in PDF content)
427
Chan W.S., Ray J.G., Murray S. et al. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch. Intern. Med. 2002; 162 (10): 1170–1175.
(check this in PDF content)
428
Balan K.K., Critchley M., Vedavathy K.K. et al. The value of ventilation-perfusion imaging in pregnancy. Br. J. Radiol. 1997; 70 (832): 338–340.
(check this in PDF content)
429
Bourjeily G., Khalil H., Raker C. et al. Outcomes of negative multi-detector computed tomography with pulmonary angiography in pregnant women suspected of pulmonary embolism. Lung. 2012; 190 (1): 105–111.
(check this in PDF content)
430
Bajc M., Neilly J.B., Miniati M. et al. EANM guidelines for ventilation / perfusion scintigraphy: Part 1. Pulmonary imaging with ventilation / perfusion single photon emission tomography.Eur. J. Nucl. Med. Mol. Imaging.2009; 36 (8): 1356–1370.
(check this in PDF content)
431
Chunilal S.D., Bates S.M. Venousthromboembolism in pregnancy: diagnosis, management and prevention. Thromb. Haemost.2009; 101 (3): 428–438.
(check this in PDF content)
432
Romualdi E., Dentali F., Rancan E. et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. Thromb. Haemost. 2013; 11 (2): 270–281.
(check this in PDF content)
433
Greer I.A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005; 106 (2): 401–407.
(check this in PDF content)
434
Rodie V.A., Thomson A.J., Stewart F.M. et al. Lowmolecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. Br. J. Obstet. Gynae* col.2002; 109 (9): 1020–1024.
(check this in PDF content)
435
Lepercq J., Conard J., Borel-Derlon A. et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. Br. J. Obstet. Gynaecol. 2001; 108 (11): 1134–1140.
(check this in PDF content)
436
Bates S.M., Greer I.A., Middeldorp S. et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9thed: American College of Chest. Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2, Suppl.): e691S–e736S.
(check this in PDF content)
437
Segal J.B., Streiff M.B., Hofmann L.V. et al. Management of venous thromboembolism: a systematic review for a practice guideline. Ann. Intern. Med.2007; 146 (3): 211–222.
(check this in PDF content)
438
Leonhardt G., Gaul C., Nietsch H.H. et al. Thrombolytic therapy in pregnancy. Thromb. Thrombolysis. 2006; 21 (3): 271–276.
(check this in PDF content)
439
Cronin-Fenton D.P., Søndergaard F., Pedersen L.A. et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. Br. J. Cancer. 2010; 103 (7): 947–953.
(check this in PDF content)
440
Palumbo A., Cavo M., Bringhen S. et al. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myelomatreated with thalidomide: a phase III, open-label, randomized trial. J. Clin. Oncol. 2011; 29 (8): 986–993.
(check this in PDF content)
441
Akl E.A., Vasireddi S.R., Gunukula S. et al. Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst. Rev.2011; (4): CD006468.
(check this in PDF content)
442
Sweetland S., Green J., Liu B. et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. Br. Med. J. 2009; 339: b4583.
(check this in PDF content)
443
Douma R.A., van Sluis G.L., Kamphuisen P.W. et al. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations. Thromb. Haemost. 2010; 104 (4): 831–836.
(check this in PDF content)
444
Dentali F., Ageno W., Becattini C. et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis.Thromb. Res. 2010; 125 (6): 518–522.
(check this in PDF content)
445
Engelke C., Manstein P., Rummeny E.J., Marten K. Suspected and incidental pulmonary embolism on multidetector-row CT: analysis of technical and morphological factors influencing the diagnosis in a cross-sectional cancer centre patient cohort. Clin. Radiol. 2006; 61 (1): 71–80.
(check this in PDF content)
446
Paddon A.J. Incidental pulmonary embolism detected by routine CT in patients with cancer. Cancer Imaging.2005; 5 (1): 25–26.
(check this in PDF content)
447
Exter P.L., Hooijer J., Dekkers O.M., Huisman M.V. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.J. Clin. Oncol. 2011; 29 (17): 2405–2409.
(check this in PDF content)
448
Abdel-Razeq H.N., Mansour A.H., Ismael Y.M. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome: a comprehensive cancer center experience. Vasc. Health Risk Manag. 2011; 7: 153–158.
(check this in PDF content)
449
Sun J.M., Kim T.S., Lee J. et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy.Lung Cancer. 2010; 69 (3): 330–336.
(check this in PDF content)
450
Ruíz-Giménez N., Suárez C., González R. et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb. Haemost.2008; 100 (1): 26–31.
(check this in PDF content)
451
Nieto J.A., Camara T., González-Higueras E. et al. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry. Thromb. Haemost. 2008; 100 (5): 789–796.
(check this in PDF content)
452
Levitan N., Dowlati A., Remick S.C. et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine(Baltimore). 1999; 78 (5): 285–291.
(check this in PDF content)
453
Louzada M.L., Carrier M., Lazo-Langner A. et al. Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Circulation. 2012; 126 (4): 448–454.
(check this in PDF content)
454
Trujillo-Santos J., Nieto J.A., Tiberio G. et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb. Haemost.2008; 100 (3): 435–439.
(check this in PDF content)
455
Carrier M., Le Gal G., Cho R. et al. Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients. Thromb. Haemost.2009; 7 (5): 760–765.
(check this in PDF content)
456
Barginear M.F., Gralla R.J., Bradley T.P. et al. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Support Care Cancer. 2012; 20 (11): 2865–2872.
(check this in PDF content)
457
Trujillo-Santos J., Prandoni P., Rivron-Guillot K. et al. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. Thromb. Haemost. 2008; 6 (2): 251–255.
(check this in PDF content)
458
Sørensen H.T., Svaerke C., Farkas D.K. et al. Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur. J. Cancer. 2012; 48 (4): 586–593.
(check this in PDF content)
459
Di Nisio M., Otten H.M., Piccioli A. et al. Decision analysis for cancer screening in idiopathic venous thromboembolism. Thromb. Haemost.2005; 3 (11): 2391–2396.
(check this in PDF content)
460
Doormaal F.F., Terpstra W., Van Der Griend R. et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted?Thromb. Haemost. 2011; 9 (1): 79–84.
(check this in PDF content)
461
Farge D., Debourdeau P., Beckers M. et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Thromb. Haemost.2013; 11 (1): 56–70.
(check this in PDF content)
462
Mandala M., Falanga A., Roila F. et al. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann. Oncol. 2011; 22 Suppl. 6: vi85–vi92.
(check this in PDF content)
463
Paddon A.J. Incidental pulmonary embolismdetected by routine CT in patients with cancer. Cancer Imaging. 2005; 5 (1): 25–26.
(check this in PDF content)
464
Montagnana M., Cervellin G., Franchini M., Lippi G. Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism. Thromb. Thrombolysis.2011; 31 (4): 436–444.
(check this in PDF content)
465
Bach A.G., Restrepo C.S., Abbas J. et al. Imaging of nonthrombotic pulmonary embolism: biological materials, nonbiological materials, and foreign bodies. Eur. J. Radiol. 2013; 82 (3): e120–e141.
(check this in PDF content)
466
Sakuma M., Sugimura K., Nakamura M. et al. Unusual pulmonary embolism: septic pulmonary embolism and amniotic fluid embolism. Circ. J. 2007; 71 (5): 772–775.
(check this in PDF content)
467
Wolf F., Schernthaner R.E., Dirisamer A. et al. Endovascular management of lost or misplaced intravascular objects: experiences of 12 years. Cardiovasc. Intervent. Radiol.2008; 31 (3): 563–568.
(check this in PDF content)
468
Parisi D.M., Koval K., Egol K. Fat embolism syndrome. Am. J. Orthop. (Belle Mead NJ). 2002; 31 (9): 507–512.
(check this in PDF content)
469
Jorens P.G., Van M.E., Snoeckx A., Parizel P.M. Nonthrombotic pulmonary embolism. Eur. Respir. J. 2009; 34 (2): 452–474.
(check this in PDF content)
470
Lin C.C., Liu P.H., Kao S.J., Chen H.I. Effects of phorbol myristate acetate and sivelestat on the lung injury caused by fat embolism in isolated lungs.J. Biomed. Sci. 2012; 19: 3.
(check this in PDF content)
471
Orebaugh S.L. Venous air embolism: clinical and experimental considerations. Crit. Care Med.1992; 20 (8): 1169–1177.
(check this in PDF content)
472
Muth C.M., Shank E.S. Gas embolism. N. Engl. J. Med. 2000; 342 (7): 476–482.
(check this in PDF content)
473
Knight M., Berg C., Brocklehurst P. et al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth. 2012; 12: 7.
(check this in PDF content)
474
Roberts K.E., Hamele-Bena D., Saqi A. et al. Pulmonary tumor embolism: a review of the literature. Am. J. Med. 2003; 115 (3): 228–232. Поступила 09.11.15 УДК616.1316005.6/7(072)
(check this in PDF content)